Procedure code and Description
MRI Abdomen W/O Contrast 74181
MRI Extremity Lower W W/O Contrast Tib/Fib, Mid/Foreft, Femur, Foreft/Toes 73720
MRI Extremity Upper Joint W/O Contrast – Shoulder, Elbow, Wrist 73221
MRI Spine Cervical W/O Contrast 72141
MRI Abdomen W W/O Contrast 74183
MRI Spine Cervical W W/O Contrast 72156
MRI Brain W/O Contrast 70551
MRI Extremity Lower Joint W/O Contrast – Knee, Ankle, Mid/Hindfoot, Hip 73721
MRI Extremity Upper Joint W W/O Contrast – Shoulder, Elbow, Wrist 73223
MRI Spine Lumbar W/O Contrast 72148
MRI Brain W W/O Contrast 70553
MRI Spine Lumbar W W/O Contrast 72158
MRI Breast MRI W W/O Contrast Contrast 77059
MRI Extremity Lower Joint W W/O – Knee, Ankle, Mid/Hindfoot, Hip 73723
MRI Enterography W W/O Contrast 74183, 72197
MRI Spine Thoracic W/O Contrast 72146
MRI Spine Thoracic W W/O Contrast 72157
MRI Chest W/O Contrast 71550
MRI Extremity Upper W/O Contrast 73218
MRI Orbit, Face, Neck W/O Contrast 70540
MRI TMJ W/O Contrast 70336
MRI Chest W W/O Contrast 71552
MRI Orbit, Face, Neck W W/O Contrast 70543
MRI Extremity Lower W/O Contrast Tib/Fib, Mid/Foreft, Femur, Foreft/Toes 73718
MRI Extremity Upper W W/O Contrast Brachial Plexus, Scapula, Humerus, Forearm, Hand 73220
MRI Pelvis W/O Contrast 72195
MRI Pelvis W W/O Contrast 72197
- MRI is considered the preferred initial choice when the following disorders are present or suspected:
- Any suspected mass or lesion.
- General symptoms, such as headache and mental status changes, which might signal significant CNS pathology.Focused efforts will be made to track the utilization of MRI for the evaluation of such presentations, in the context of determining if appropriate, preliminary diagnostic steps have been undertaken.
- Evaluation of pituitary or juxtasellar lesions.
- Evaluation of complicated seizure syndromes, particularly when a temporal lobe focus is suspected.
- Suspected CNS infections.
- Vasculitis.
- Vascular malformations, including arterial or venous/dural sinus abnormalities.
- Ischemic disease and infarction, including presenting symptoms such as aphasia.
- Aneurysm.
- Brain maturation abnormalities.
- Hydrocephalus.
- Demyelinating disorders, e.g., multiple sclerosis.
- Hearing loss suggestive of a sensorineural lesion.
- Orbital lesions.
- Any cranial nerve abnormality.
- When the pathology is localized to the posterior fossa.
- CT scanning is the preferred initial test in the following situations:
- Sinusitis.
- Hearing loss and other otolaryngologic presentations whose evaluation reaches the level of requiring such imaging.
- Unconsciousness and alteration of mental status, the latter of which may reflect atypical or rapid-onset dementia. Similar to MRI above, focused efforts will be made to track the utilization of CT for the evaluation of such presentations in the context of determining if appropriate preliminary diagnostic steps have been undertaken.
- Non-traumatic neurologic central deficit with suspicion of infarction or bleeding.
- Congenital anomalies.
- Foreign body.
- Thyroid ophthalmopathy/proptosis.
- Acute cranial trauma.
- Evaluation of a single new seizure.
- MRI may be necessary in the conditions listed in the section immediately above if there are unusual circumstances or the need for invasive intervention is high or when a multiplanar road map for surgery is needed.
- Duplex scans of the carotid are usually the initial step in evaluating signs and symptoms of a stroke or transient ischemic attack in the carotid distribution. If intervention is likely, either Magnetic Resonance Angiography (MRA) or carotid angiography would be appropriate follow-up studies. Focused efforts will be made to track the utilization of MRI as an initial imaging study where alternative modalities (duplex scans) may be more pertinent.
- Reasonable and medically necessary for the individual patient.
- Performed on a unit that has received federal Food and Drug Administration (FDA) approval. Such units must be operated within the parameters specified by that approval.
- The measurement of blood flow.
- Spectroscopy.
- Imaging of cortical bone and calcifications.
- Procedures involving spatial resolution of bone or calcifications.
- Reasonable and medically necessary for the individual patient.
- Performed on a model of CT equipment that meets CMS criteria:
- Must be known to the FDA.
- Must be in the full market release phase of development.
- Safe and effective.
- Not experimental or investigational (exception: routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000, which meet the requirements of the clinical trials NCD are considered reasonable and necessary).
- Appropriate, including the duration and frequency that is considered appropriate for the service, in terms of whether it is:
- Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member.
- Furnished in a setting appropriate to the patient’s medical needs and condition.
- Ordered and furnished by qualified personnel.
- One that meets, but does not exceed, the patient’s medical need.
- At least as beneficial as an existing and available medically appropriate alternative.
CPT/HCPCS Codes
70450© Ct head/brain w/o dye – Fee amount $114.38
70460© Ct head/brain w/dye
70470© Ct head/brain w/o & w/dye
70540© Mri orbit/face/neck w/o dye
70542© Mri orbit/face/neck w/dye
70543© Mri orbt/fac/nck w/o & w/dye
70551© Mri brain w/o dye
70552© Mri brain w/dye
70553© Mri brain w/o & w/dye
70557© Mri brain w/o dye
70558© Mri brain w/dye
70559© Mri brain w/o & w/dye
|
Computerized tomography (CT scanning) uses the attenuation of an x-ray beam by an object in its path to create cross-sectional images. As x-rays pass through planes of the body, the photons are detected and recorded as they exit from different angles. Computers process the signals to produce a cross-sectional view of the body. The signal data may be subjected to a variety of post-acquisitional processing algorithms to obtain a multiplanar view of the anatomy.
Magnetic Resonance Imaging (MRI)
Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic scanning technique that employs a powerful and highly uniform static magnetic field, rather than ionizing radiation, to produce images. Fluctuations in the strength of the magnetic field alter the motion and relaxation times of hydrogen molecules, which are related to the density of molecules and reflect the physicochemical properties of the tissues. Reconstructed images can be displayed in multiple planes to facilitate analysis. See national non-coverage in CMS section above.
Coverage is limited to those CT and MRI machines that have received pre-market approval by the FDA. Such units must be operated within the parameters specified by the approval.
Medicare coverage for CT scans is allowed provided the service is medically reasonable and necessary.
Inconclusive findings on a CT scan may warrant a MRI study and, conversely, findings of a MRI study may be further clarified (under certain circumstances) with a subsequent CT scan. The information provided by the two modalities may be complementary.
Cancer Staging. Clinicians commonly use CT and MRI of the brain when metastatic involvement is suspected.
Non-covered indications: esophagus, oropharynx, and prostate, and non-melanoma skin cancer in the absence of symptoms of brain involvement. “Certain tumors almost never metastasize to the brain parenchyma. These include carcinomas of the esophagus, oropharynx, and prostate, and non-melanoma skin cancers.” (DeVita, Chapter 52.1) Accordingly, the related diagnoses found in the following diagnosis code list do not justify brain scans for “staging” purposes unless a patient has signs or symptoms suggesting brain involvement. Covered: In contrast, for those malignancies that commonly metastasize to the brain, staging in the absence of neurological findings may be appropriate.
Payment will be allowed for reasonable and necessary scans of different areas of the body that are performed on the same day.
Billing and Coding Guidelines
CPT code will not be paid when we are submitting with these codes unless correct Modifier has been used
70480 70481 70482 76380
General Guidelines – Brain CT ✓ Head CT without contrast (CPT® 70450) in nearly all cases, to show:
* mass effect
* blood/blood products
* abnormal tissue o MRI without and with contrast may be performed to follow-up abnormalities seen on CT without contrast when a mass, lesion, or infection is found
* MRI without contrast may be performed to follow-up abnormalities seen on CT without contrast when there is suspected Multiple Sclerosis or other demyelinating disease
Allowable billed grouping are 70450 or 70460 or 70470 or 76380
Billing with Modifier 26 and TC
A patient seeks treatment at the Emergency Room (ER) of a hospital for a head injury. The facility performs a CT of the head without contrast (CPT Code 70450). The film is sent by courier to a noted local radiologist’s office for review. The radiologist reads/interprets the CT film and seeing no sign of injury or damage calls the hospital’s ER and advises them to release the patient.
The facility will submit a claim for providing the technical component of the service with the following claim elements:
CPT Code 70450
Modifier TC (to indicate the technical component)
POS 23
Formula Used to Determine Bundled Amount – 100% of the procedure with the highest RVU, 50% of the second
Payment with and without Modifiers
70450 Ct head/brain w/o dye $116.78 $116.44 -0.3%
70450 26 Ct head/brain w/o dye $43.48 $43.35 -0.3%
70450 TC Ct head/brain w/o dye $73.30 $73.09 -0.3%
CPT Code for MRI Brain, Breast, Lumbar Spine and Shoulder
CPT Codes for MRI Lumbar spine
In human Lumbar spine is represented by the 5 vertebrae in between the ribcage and the pelvis forming the largest segment of the vertebral column. Depending on the condition that one is treated on these parts of the body. Here under are the CPT Codes for MRI Lumbar spine that are usually used for the purposes of billing and coding of Lumbar spine MRI procedures:
CPT 72148 MRI Lumbar Spine Without Contrast
CPT 72149 MRI Lumbar Spine With Contrast
CPT 72158 MRI Lumbar Spine With and Without Contrast
CPT 97110 Therapeutic procedure, one or more areas, each 15 minutes; therapeutic exercise to develop strength and endurance, range of motion and flexibility
CPT 97112 Neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities
CPT 97113 Aquatic therapy with therapeutic exercises
CPT 97124 Massage, including effleurage, petrissage and/or tapotement (stroking, compression, percussion)
CPT 97140 Manual therapy technical (e.g. mobilization/manipulation, manual
CPT 98940 Chiropractic manipulative treatment (CMT); spinal, one to two regions
CPT 98941 spinal, three to four regions
CPT 98942 spinal, five regions
CPT 98943 extra spinal, one or more regions
CPT Codes for Brain/Head MRI/MRA/MRV with and without Contrast
The commonly used CPT codes for the Brain/Head MRI with and without Contrast are:
CPT 70551 brain/Head w/o contrast
CPT 70553 Brain/Head w/wo contrast
CPT 70544 MRA/MRV w/o contrast
CPT 70546 MRA brain w/wo contrast
CPT Codes for MRI Shoulder
Commonly used Shoulder CPT codes are given below:
CPT Code 29806 is the parent code in the shoulder scope section used to cater for any open procedures carried on the shoulder. It is CPT code responsible for Arthroscopy, shoulder, surgical; capsulorrhaphy.
CPT Code 29807 is an arthroscopic shoulder procedure code normally used when arthroscopic shoulder stabilization and stabilization is carried out
CPT Code 23472 Total shoulder Arthroplasty
CPT Code 23470 Hemiarthroplasty Shoulder
CPT Code 24363 Total Elbow Arthroplasty
CPT Code 23455 Open Bankart Repair Capsulorrhaphy, anterior; with labral repair (eg. Bankart procedure)
CPT Codes for MRI Breast Cancer Screening
Breast cancer occurs when malignant cells form in the breast tissues, there are specific CPT codes that are normally used by medical billers and coders to record any condition that one might be screened for in case of breast cancer:
CPT Code 77057 Screening mammography, bilateral
CPT Code 77052 Computer aided detection with further physician review for interpretation, with or without digitization of film radiographic images; screening mammography
CPT Code 76499 Electrical impedance scan of the breast, bilateral (risk assessment device for breast cancer)
CPT Code 99386 Initial preventive medicine evaluation and management, 40 to 64 years, new patient
CPT Code 99387 Initial preventive medicine evaluation and management, 65 years and older
CPT Code 99396 Periodic preventive medicine evaluation and management, 40 to 64 years, established patient
CPT Code 99397 Periodic preventive medicine evaluation and management, 65 years and older
CPT Codes for Breast Pumps
Although Breast Pumps Codes do not fall under Radiology category, we are mentioning them here because see a lot of Medical Coders wondering for lookup of precise breast codes to bill.
Breast pumps are generally considered durable medical equipment usually not covered as they are considered pumps for convenience. In exception conditions they are usually covered by insurance companies. The following are some of the CPT codes associated with breast pumps:
CPT Code A4281 Tubing for breast pump, replacement
CPT Code A4282 Adapter for breast pump, replacement
CPT Code A4283 Cap for breast pump bottle, replacement
CPT Code A4284 Breast shield and splash protector for use with breast pump, replacement
CPT Code A4285 Breast shield and splash protector for use with breast pump, replacement
CPT Code A4286 Locking ring for breast pump, replacement
CPT Code E0603 Breast pump, electric (ac and/or dc), any type
CPT Code E0604 Breast pump, hospital grade, electric (AC and/or DC), any type
Documentation Requirements
The documentation of the study requires a formal written report, with clear identifying demographics, the name of the interpreting provider, reason for the test, and interpretive report and copies of all images obtained. The computerized data with image reconstruction should also be maintained.
The medical record must contain documentation, including a written or electronic request for the procedure which fully supports the medical necessity of the procedure performed. This documentation includes, but is not limited to relevant medical history, physical examination, diagnosis (if known), pertinent signs and symptoms and results of pertinent diagnostic tests and/or procedures. This entire documentation-not just the test report or the findings/diagnosis on the order, must be made available upon request.
When a CT scan and MRI are performed on the same day for the same anatomical area, the medical record must clearly reflect the medical necessity for performing both tests.
If the provider of the service is other than the ordering/referring physician, that provider must maintain hard copy documentation of test results and interpretation, along with copies of the ordering/referring physician’s order for the studies. The physician must state the clinical indication/medical necessity for the study in his order for the test.
Rules for Testing Facility to Furnish Additional Tests:
If the testing facility cannot reach the treating physician/practitioner to change the order or obtain a new order and documents this in the medical record, then the testing facility may furnish the additional diagnostic test if all of the following criteria apply:
The testing center performs the diagnostic test ordered by the treating physician/practitioner;
The interpreting physician at the testing facility determines and documents that, because of the abnormal result of the diagnostic test performed, an additional diagnostic test is medically necessary;
Delaying the performance of the additional diagnostic test would have an adverse effect on the care of the beneficiary;
The result of the test is communicated to and is used by the treating physician/practitioner in the treatment of the beneficiary; and
The interpreting physician at the testing facility documents in his/her report why additional testing was done.
Rules for Testing Facility Interpreting Physician to Furnish Different or Additional Tests:
The following applies to an interpreting physician of a testing facility who furnishes a diagnostic test to a beneficiary who is not a hospital inpatient or outpatient. The interpreting physician must document accordingly in his/her report to the treating physician/practitioner.
Test Design:
Unless specified in the order, the interpreting physician may determine, without notifying the treating physician/practitioner, the parameters of the diagnostic test (e.g., number of radiographic views obtained, thickness or tomographic sections acquired, use or non-use of contrast media).
ICD-10 CODE DESCRIPTION
A02.21 Salmonella meningitis
A06.6 Amebic brain abscess
A17.0 Tuberculous meningitis
A17.1 Meningeal tuberculoma
A17.81 Tuberculoma of brain and spinal cord
A17.82 Tuberculous meningoencephalitis
A17.83 Tuberculous neuritis
A17.89 Other tuberculosis of nervous system
A17.9 Tuberculosis of nervous system, unspecified
A18.01 Tuberculosis of spine
A18.03 Tuberculosis of other bones
A18.2 Tuberculous peripheral lymphadenopathy
A18.50 Tuberculosis of eye, unspecified
A18.51 Tuberculous episcleritis
A18.52 Tuberculous keratitis
A18.53 Tuberculous chorioretinitis
A18.54 Tuberculous iridocyclitis
A18.59 Other tuberculosis of eye
A18.6 Tuberculosis of (inner) (middle) ear
A27.81 Aseptic meningitis in leptospirosis
A32.0 Cutaneous listeriosis
A32.11 Listerial meningitis
A32.12 Listerial meningoencephalitis
A32.7 Listerial sepsis
A32.81 Oculoglandular listeriosis
A32.82 Listerial endocarditis
A32.89 Other forms of listeriosis
A32.9 Listeriosis, unspecified
A39.0 Meningococcal meningitis
A39.1 Waterhouse-Friderichsen syndrome
A39.2 Acute meningococcemia
A39.3 Chronic meningococcemia
A39.4 Meningococcemia, unspecified
A39.50 Meningococcal carditis, unspecified
A39.51 Meningococcal endocarditis
A39.52 Meningococcal myocarditis
A39.53 Meningococcal pericarditis
A39.81 Meningococcal encephalitis
A39.82 Meningococcal retrobulbar neuritis
A39.83 Meningococcal arthritis
A39.84 Postmeningococcal arthritis
A39.89 Other meningococcal infections
A39.9 Meningococcal infection, unspecified
A41.9 Sepsis, unspecified organism
A50.30 Late congenital syphilitic oculopathy, unspecified
A50.32 Late congenital syphilitic chorioretinitis
A50.39 Other late congenital syphilitic oculopathy
A50.40 Late congenital neurosyphilis, unspecified
A50.41 Late congenital syphilitic meningitis
A50.42 Late congenital syphilitic encephalitis
A50.43 Late congenital syphilitic polyneuropathy
A50.44 Late congenital syphilitic optic nerve atrophy
A50.45 Juvenile general paresis
A50.49 Other late congenital neurosyphilis
A50.51 Clutton’s joints
A50.52 Hutchinson’s teeth
A50.53 Hutchinson’s triad
A50.54 Late congenital cardiovascular syphilis
A50.55 Late congenital syphilitic arthropathy
A50.56 Late congenital syphilitic osteochondropathy
A50.57 Syphilitic saddle nose
A50.59 Other late congenital syphilis, symptomatic
A51.41 Secondary syphilitic meningitis
A51.49 Other secondary syphilitic conditions
A52.00 Cardiovascular syphilis, unspecified
A52.10 Symptomatic neurosyphilis, unspecified
A52.11 Tabes dorsalis
A52.12 Other cerebrospinal syphilis
A52.13 Late syphilitic meningitis
A52.14 Late syphilitic encephalitis
A52.15 Late syphilitic neuropathy
A52.16 Charcot’s arthropathy (tabetic)
A52.17 General paresis
A52.19 Other symptomatic neurosyphilis
A52.2 Asymptomatic neurosyphilis
A52.3 Neurosyphilis, unspecified
A54.81 Gonococcal meningitis
A80.0 Acute paralytic poliomyelitis, vaccine-associated
A80.1 Acute paralytic poliomyelitis, wild virus, imported
A80.2 Acute paralytic poliomyelitis, wild virus, indigenous
A80.30 Acute paralytic poliomyelitis, unspecified
A80.39 Other acute paralytic poliomyelitis
A80.4 Acute nonparalytic poliomyelitis
A80.9 Acute poliomyelitis, unspecified
A81.00 Creutzfeldt-Jakob disease, unspecified
A81.01 Variant Creutzfeldt-Jakob disease
A81.09 Other Creutzfeldt-Jakob disease
A81.1 Subacute sclerosing panencephalitis
A81.2 Progressive multifocal leukoencephalopathy
A81.81 Kuru
A81.82 Gerstmann-Straussler-Scheinker syndrome
A81.83 Fatal familial insomnia
A81.89 Other atypical virus infections of central nervous system
A81.9 Atypical virus infection of central nervous system, unspecified
A82.0 Sylvatic rabies
A82.1 Urban rabies
A82.9 Rabies, unspecified
A83.0 Japanese encephalitis
A83.1 Western equine encephalitis
A83.2 Eastern equine encephalitis
ICD-9-CM Codes that Support Medical Necessity
013.00–013.06
|
Tuberculous meningitis
|
013.10–013.16
|
Tuberculoma of meninges
|
013.20–013.26
|
Tuberculoma of brain
|
013.30–013.36
|
Tuberculous abscess of brain
|
013.60–013.66
|
Tuberculous encephalitis or myelitis
|
013.80–013.86
|
Other specified tuberculosis of central nervous system
|
013.90–013.96
|
Unspecified tuberculosis of central nervous system
|
015.60–015.66
|
Tuberculous mastoiditis
|
015.70–015.76
|
Tuberculosis of other specified bone
|
017.20–017.26
|
Tuberculosis of peripheral lymph nodes
|
017.30–017.36
|
Tuberculosis of eye
|
017.40–017.46
|
Tuberculosis of ear
|
017.50–017.56
|
Tuberculosis of thyroid gland
|
036.0–036.1
|
Meningococcal infection
|
036.3
|
Waterhouse-friderichsen syndrome meningococcal
|
038.9
|
Unspecified septicemia
|
042
|
HIV disease
|
045.00–045.03
|
Acute paralytic poliomyelitis specified as bulbar
|
045.10–045.13
|
Acute poliomyelitis with other paralysis
|
045.20–045.23
|
Acute non-paralytic poliomyelitis
|
045.90–045.93
|
Acute poliomyelitis, unspecified
|
046.0
|
Kuru
|
046.11
|
Variant Creutzfeldt-Jakob disease
|
046.19
|
Other and unspecified Creutzfeldt-Jakob disease
|
046.2
|
Subacute sclerosing panencephalitis
|
046.3
|
Progressive multifocal leukoencephalopathy
|
046.8–046.9
|
Slow virus infection of central nervous system
|
047.0–047.1
|
Meningitis due to enterovirus
|
047.8–047.9
|
Other specified or unspecified viral meningitis
|
048
|
Other enterovirus diseases of central nervous system
|
049.0–049.1
|
Other non-arthropod-borne viral disease of the central nervous system
|
049.8–049.9
|
Other non-arthropod-borne viral disease of the central nervous system
|
052.0
|
Post-varicella encephalitis
|
052.2
|
Postvaricella myelitis
|
053.0
|
Herpes zoster with meningitis
|
053.10
|
Herpes zoster with unspecified nervous system complication
|
053.14
|
Herpes zoster myelitis
|
053.20
|
Herpes zoster dermatitis of eyelid
|
054.3
|
Herpetic meningoencephalitis
|
054.40
|
Herpes simplex with unspecified ophthalmic complication
|
054.72
|
Herpes simplex meningitis
|
054.74
|
Herpes simplex myelitis
|
055.0
|
Post-measles encephalitis
|
056.00–056.01
|
Rubella with neurological complications
|
056.09
|
Other neurological complications due to rubella
|
056.79
|
Rubella with other specified complications
|
062.0–062.5
|
Mosquito-borne viral encephalitis
|
062.8–062.9
|
Mosquito-borne viral encephalitis
|
063.0–063.2
|
Tick-borne viral encephalitis
|
063.8–063.9
|
Tick-borne viral encephalitis
|
064
|
Viral encephalitis transmitted by other and unspecified arthropods
|
071
|
Rabies
|
072.1–072.2
|
Mumps
|
078.5
|
Cytomegaloviral (CMV) disease
|
079.51
|
Human T-cell lymphotropic virus, type I
|
079.99
|
Unspecified viral infection
|
090.40–090.42
|
Juvenile neurosyphilis
|
090.49
|
Other juvenile neurosyphilis
|
090.5–090.7
|
Juvenile neurosyphilis
|
090.9
|
Other congenital syphilis, unspecified
|
094.0–094.3
|
Neurosyphilis
|
094.81–094.87
|
Other specified neurosyphilis
|
094.89
|
Other specified neurosyphilis
|
094.9
|
Neurosyphilis, unspecified
|
112.83
|
Candidal meningitis
|
114.2
|
Coccidioidal meningitis
|
115.01
|
Histoplasma capsulatum meningitis
|
115.11
|
Histoplasma duboisii meningitis
|
115.91
|
Histoplasmosis meningitis unspecified
|
117.3
|
Aspergillosis
|
117.5
|
Cryptococcosis
|
118
|
Opportunistic mycoses
|
123.1
|
Cysticercosis
|
124
|
Trichinosis
|
130.0
|
Meningoencephalitis due to toxoplasmosis
|
135
|
Sarcoidosis
|
136.21
|
Specific infection due to acanthamoeba
|
136.29
|
Other specific infections by free-living amebae
|
136.9
|
Unspecified infectious and parasitic diseases
|
137.1
|
Late effects of CNS tuberculosis
|
139.0
|
Late effects of viral encephalitis
|
140.0–140.1
|
Malignant neoplasm of lip
|
140.3–140.6
|
Malignant neoplasm of lip
|
140.8–140.9
|
Malignant neoplasm of lip
|
141.0–141.6
|
Malignant neoplasm of tongue
|
141.8–141.9
|
Malignant neoplasm of tongue
|
142.0–142.2
|
Malignant neoplasm of major salivary glands
|
142.8–142.9
|
Malignant neoplasm of major salivary glands
|
143.0–143.1
|
Malignant neoplasm of gum
|
143.8–143.9
|
Malignant neoplasm of gum
|
144.0–144.1
|
Malignant neoplasm of floor of mouth
|
144.8–144.9
|
Malignant neoplasm of floor of mouth
|
145.0–145.6
|
Malignant neoplasm of other and unspecified parts of mouth
|
145.8–145.9
|
Malignant neoplasm of other and unspecified parts of mouth
|
146.0–146.9
|
Malignant neoplasm of oropharynx
|
147.0–147.3
|
Malignant neoplasm of nasopharynx
|
147.8–147.9
|
Malignant neoplasm of nasopharynx
|
148.0–148.3
|
Malignant neoplasm of hypopharynx
|
148.8–148.9
|
Malignant neoplasm of hypopharynx
|
149.0–149.1
|
Malignant neoplasm of other and ill-defined sites within the lip, oral cavity and pharynx
|
149.8–149.9
|
Malignant neoplasm of other and ill–defined sites within the lip, oral cavity and pharynx
|
150.0–150.5
|
Malignant neoplasm of esophagus
|
150.8–150.9
|
Malignant neoplasm of esophagus
|
160.0–160.5
|
Malignant neoplasm of nasal cavities, middle ear and accessory sinuses
|
160.8–160.9
|
Malignant neoplasm of nasal cavities, middle ear and accessory sinuses
|
161.0–161.3
|
Malignant neoplasm of larynx
|
161.8–161.9
|
Malignant neoplasm of larynx
|
162.0
|
Malignant neoplasm of trachea
|
162.2–162.5
|
Malignant neoplasm of trachea, bronchus and lung
|
162.8–162.9
|
Malignant neoplasm of trachea, bronchus and lung
|
170.0–170.1
|
Malignant neoplasm of bone and articular cartilage
|
170.9
|
Malignant neoplasm of bone and articular cartilage, site unspecified
|
171.0
|
Malignant neoplasm of connective and other soft tissue of head, face and neck
|
172.0–172.9
|
Malignant melanoma of skin
|
173.0–173.8
|
Malignant neoplasm of skin
|
190.0–190.9
|
Malignant neoplasm of eye
|
191.0–191.9
|
Malignant neoplasm of brain
|
192.0–192.1
|
Malignant neoplasm of other and unspecified sites of nervous system
|
192.8
|
Malignant neoplasm of other specified sites of nervous system
|
193
|
Malignant neoplasm of thyroid gland
|
194.1
|
Malignant neoplasm of parathyroid gland
|
194.3–194.4
|
Malignant neoplasm of other endocrine glands and related structures
|
195.0
|
Malignant neoplasm of other and ill-defined sites – head, face, neck
|
196.0
|
Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck
|
198.3–198.5
|
Secondary malignant neoplasm of other specified sites
|
199.0–199.2
|
Malignant neoplasm without specification of site
|
200.00–200.01
|
Reticulosarcoma
|
200.10–200.11
|
Lymphosarcoma
|
200.20–200.21
|
Burkitt’s tumor or lymphoma
|
200.30–200.38
|
Marginal zone lymphoma
|
200.40–200.48
|
Mantle cell lymphoma
|
200.50–200.58
|
Primary central nervous system lymphoma
|
200.60–200.68
|
Anaplastic large cell lymphoma
|
200.70–200.78
|
Large cell lymphoma
|
200.80–200.81
|
Lymphosarcoma and reticulosarcoma
|
202.80–202.81
|
Other lymphomas
|
202.90–202.91
|
Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
|
203.00–203.02
|
Multiple myeloma
|
203.10–203.12
|
Plasma cell leukemia
|
203.80–203.82
|
Other immunoproliferative neoplasms
|
208.90-208.92
|
Unspecified leukemia without mention of remission
|
210.0–210.9
|
Benign neoplasm of lip, oral cavity and pharynx
|
212.0–212.1
|
Benign neoplasm of respiratory and intrathoracic organs
|
213.0–213.1
|
Benign neoplasm of bone and articular cartilage
|
213.9
|
Benign neoplasm of bone and articular cartilage, site unspecified
|
214.0
|
Lipoma, skin and subcutaneous tissue of face
|
214.8
|
Lipoma, other specified sites
|
215.0
|
Other benign neoplasm of head, face and neck
|
215.8
|
Other benign neoplasm of other specified sites
|
224.0–224.9
|
Benign neoplasm of eye
|
225.0–225.4
|
Benign neoplasm of brain and other parts of nervous system
|
225.8–225.9
|
Benign neoplasm of brain and other parts of nervous system
|
227.1
|
Benign neoplasm of parathyroid gland
|
227.3–227.4
|
Benign neoplasm of other endocrine glands and related structures
|
228.02
|
Hemangioma of intracranial structures
|
228.09
|
Hemangioma of other sites
|
230.0
|
Carcinoma in situ of lip, oral cavity and pharynx
|
231.0–231.1
|
Carcinoma in situ of respiratory system
|
232.0–232.4
|
Carcinoma in situ of skin
|
235.0–235.1
|
Neoplasm of uncertain behavior of digestive and respiratory systems
|
235.6
|
Neoplasm of uncertain behavior of larynx
|
235.9
|
Neoplasm of uncertain behavior of other and unspecified respiratory organs (sinuses, middle ear, nasal cavities)
|
237.0
|
Neoplasm of uncertain behavior of pituitary gland and craniopharyngeal duct
|
237.1
|
Neoplasm of uncertain behavior of pineal gland
|
237.3–237.6
|
Neoplasm of uncertain behavior of other and unspecified endocrine glands and nervous system
|
237.70–237.73
|
Neoplasm of uncertain behavior of neurofibromatosis
|
237.79
|
Other neurofibromatosis
|
237.9
|
Neoplasm of uncertain behavior of other and unspecified parts of nervous system
|
238.0
|
Neoplasm of uncertain behavior of bone and articular cartilage
|
238.4–238.5
|
Neoplasm of uncertain behavior of other and unspecified sites and tissues
|
238.72–238.75
|
Other lymphatic and hematopoietic tissues
|
238.8
|
Neoplasm of uncertain behavior of other specified sites
|
239.2
|
Neoplasm of unspecified nature of bone, soft tissue and skin
|
239.6–239.7
|
Neoplasm of unspecified nature
|
239.81
|
Neoplasms of unspecified nature, retina and choroid
|
239.89
|
Neoplasms of unspecified nature, other specified sites
|
251.2
|
Hypoglycemia, unspecified
|
252.00–252.02
|
Hyperparathyroidism
|
252.08
|
Hyperparathyroidism
|
253.0
|
Acromegaly and gigantism
|
253.1–253.9
|
Disorders of the pituitary gland and its hypothalamic control
|
255.0
|
Cushing’s syndrome
|
277.30
|
Amyloidosis, unspecified
|
282.41–282.42
|
Thalassemias
|
282.49
|
Other thalassemia
|
282.5
|
Sickle-cell trait anemias
|
282.60–282.63
|
Sickle-cell disease
|
282.69
|
Sickle-cell anemia, other with crisis
|
287.30
|
Primary thrombocytopenia,unspecified
|
289.0
|
Polycythemia, secondary
|
289.6
|
Familial polycythemia
|
290.0
|
Senile dementia, uncomplicated
|
290.10–290.13
|
Presenile dementia
|
290.20–290.21
|
Senile dementia with delusional or depressive features
|
290.3
|
Senile dementia with delirium
|
290.40–290.43
|
Arteriosclerotic dementia
|
290.8–290.9
|
Arteriosclerotic dementia
|
291.0–291.2
|
Alcoholic psychoses
|
293.0–293.1
|
Transient organic psychotic conditions
|
293.81–293.84
|
Other specified transient organic mental disorders
|
293.89
|
Other specific transient organic mental disorders
|
293.9
|
Other organic psychotic conditions
|
294.0
|
Amnestic syndrome
|
294.10–294.11
|
Dementia in conditions classified elsewhere
|
294.8–294.9
|
Dementia in conditions classified elsewhere
|
295.00–295.05
|
Schizophrenic disorders, simple type
|
295.10–295.15
|
Schizophrenic disorders, disorganized type
|
295.20–295.25
|
Schizophrenic disorders, catatonic type
|
295.30–295.35
|
Schizophrenic disorders, paranoid type
|
295.40–295.45
|
Schizophrenic disorders, acute schizophrenic episode
|
295.50–295.55
|
Schizophrenic disorders, latent schizophrenia
|
295.60–295.65
|
Schizophrenic disorders, residual schizophrenia
|
295.70–295.75
|
Schizophrenic disorders, schizo-affective type
|
295.80–295.85
|
Schizophrenic disorders, other specified types of schizophrenia
|
295.90–295.95
|
Schizophrenic disorders, unspecified schizophrenia
|
296.00–296.06
|
Affective psychoses, manic disorder, single episode
|
296.10–296.15
|
Affective psychoses, manic disorder, recurrent episode
|
296.20–296.26
|
Affective psychoses, major depressive disorder, single episode
|
296.30–296.36
|
Affective psychoses, major depressive disorder, recurrent episode
|
296.40–296.46
|
Affective psychoses, bipolar affective disorder, manic
|
296.50–296.56
|
Affective psychoses, bipolar affective disorder, depressed
|
296.60–296.66
|
Affective psychoses, bipolar affective disorder, mixed
|
296.7
|
Affective psychoses, bipolar affective disorder, unspecified
|
296.80–296.82
|
Affective psychoses, manic depressive psychosis, other and unspecified
|
296.89
|
Affective psychoses, other manic depressive psychosis
|
296.90
|
Affective psychoses, unspecified affective psychosis
|
296.99
|
Affective psychoses, other specified affective psychosis
|
297.0–297.3
|
Paranoid states (delusional disorders)
|
297.8–297.9
|
Paranoid states (delusional disorders)
|
298.0–298.4
|
Other non-organic psychosis
|
298.8–298.9
|
Other non-organic psychosis
|
305.20–305.23
|
Non-dependent abuse of drugs, cannabis abuse
|
305.30–305.33
|
Non-dependent abuse of drugs, hallucinogen abuse
|
305.40–305.43
|
Non-dependent abuse of drugs, barbiturate and similarly acting sedative or hypnotic abuse
|
305.50–305.53
|
Non-dependent abuse of drugs, opioid abuse
|
305.60–305.63
|
Non-dependent abuse of drugs, cocaine abuse
|
305.70–305.73
|
Non-dependent abuse of drugs, amphetamine or related acting sympathomimetic abuse
|
305.80–305.83
|
Non-dependent abuse of drugs, antidepressant type abuse
|
305.90–305.93
|
Non-dependent abuse of drugs, other, mixed, or unspecified drug abuse
|
310.0–310.2
|
Specific non-psychotic mental disorders due to organic brain damage
|
310.8–310.9
|
Specific non-psychotic mental disorders due to organic brain damage
|
311
|
Depressive disorder, not elsewhere classified
|
320.0–320.3
|
Bacterial meningitis
|
320.7
|
Meningitis in other bacterial diseases classified elsewhere
|
320.81–320.82
|
Meningitis due to other specified bacteria
|
320.89
|
Meningitis due to other specified bacteria
|
320.9
|
Meningitis due to unspecified bacterium
|
321.0–321.4
|
Meningitis due to other organisms
|
321.8
|
Meningitis due to other non-bacterial organisms classified elsewhere
|
322.0–322.2
|
Meningitis of unspecified cause
|
322.9
|
Meningitis, unspecified
|
323.01–323.02
|
Encephalitis and encephalomyelitis in viral diseases classified elsewhere – Myelitis in viral diseases classified elsewhere
|
323.2
|
Encephalitis, myelitis and encephalomyelitis
|
323.41–323.42
|
Other encephalitis and encephalomyelitis due to infection classified elsewhere – Other myelitis due to infection classified elsewhere
|
323.51
|
Encephalitis and encephalomyelitis following immunization procedures
|
323.61–323.63
|
Infectious acute disseminated encephalomyelitis (ADEM) – Postinfectious myelitis
|
323.71–323.72
|
Toxic encephalitis and encephalomyelitis – Toxic myelitis
|
323.81–323.82
|
Other causes of encephalitis and encephalomyelitis – Other causes of myelitis
|
323.9
|
Unspecified causes of encephalitis, myelitis, and encephalomyelitis
|
324.0–324.1
|
Intracranial and intraspinal abscess
|
324.9
|
Intracranial and intraspinal abscess of unspecified site
|
325
|
Phlebitis and thrombophlebitis of intracranial venous sinuses
|
326
|
Late effects of intracranial infection or pyogenic abscess
|
330.0–330.3
|
Cerebral degenerations usually manifest in childhood
|
330.8–330.9
|
Cerebral degenerations usually manifest in childhood
|
331.0
|
Alzheimer’s disease
|
331.11
|
Pick’s disease
|
331.19
|
Other frontotemporal dementia
|
331.2–331.4
|
Other cerebral degenerations
|
331.7
|
Cerebral degeneration in diseases classified elsewhere
|
331.81
|
Reye’s syndrome
|
331.89
|
Other cerebral degeneration
|
331.9
|
Cerebral degeneration, unspecified
|
332.0–332.1
|
Parkinson’s disease
|
333.0–333.6
|
Other degenerative diseases of the basal ganglia – Genetic torsion dystonia
|
333.71–333.72
|
Athetoid cerebral palsy – Acute dystonia due to drugs
|
333.81–333.84
|
Fragments of torsion dystonia
|
333.85
|
Subacute dyskinesia due to drugs
|
333.90–333.93
|
Other and unspecified extrapyramidal diseases and abnormal movement disorders
|
333.99
|
Other and unspecified extrapyramidal diseases and abnormal movement disorders
|
334.0–334.4
|
Spinocerebellar disease
|
334.8–334.9
|
Spinocerebellar disease
|
335.20
|
Amyotrophic lateral sclerosis
|
335.22–335.23
|
Motor neuron disease
|
340
|
Multiple sclerosis
|
341.0–341.1
|
Other demyelinating diseases of central nervous system
|
341.8–341.9
|
Other demyelinating diseases of central nervous system
|
342.00–342.02
|
Flaccid hemiplegia
|
342.10–342.12
|
Spastic hemiplegia
|
342.80–342.82
|
Other specified hemiplegia
|
342.90–342.92
|
Hemiplegia, unspecified
|
343.2–343.4
|
Infantile cerebral palsy
|
343.8–343.9
|
Infantile cerebral palsy
|
344.00–344.04
|
Quadriplegia
|
344.09
|
Other quadriplegia
|
344.1
|
Paraplegia
|
344.2
|
Diplegia of upper limbs
|
344.30–344.32
|
Monoplegia of lower limb
|
344.40–344.42
|
Monoplegia of upper limb
|
344.81
|
Locked-in state
|
344.89
|
Other specified paralytic syndrome
|
344.9
|
Paralysis unspecified
|
345.00–345.01
|
Generalized non-convulsive epilepsy
|
345.10–345.11
|
Generalized convulsive epilepsy
|
345.2–345.3
|
Epilepsy
|
345.40–345.41
|
Partial epilepsy, with impairment of consciousness
|
345.50–345.51
|
Partial epilepsy, without impairment of consciousness
|
345.60–345.61
|
Infantile spasms
|
345.70–345.71
|
Epilepsia partialis continua
|
345.80–345.81
|
Other forms of epilepsy
|
345.90–345.91
|
Epilepsy, unspecified
|
348.0–348.2
|
Other conditions of brain
|
348.30–348.31
|
Encephalopathy, NEC
|
348.39
|
Other encephalopathy
|
348.4–348.5
|
Other conditions of brain
|
348.81
|
Temporal sclerosis
|
348.89
|
Other conditions of brain
|
348.9
|
Unspecified conditions of brain
|
349.0–349.2
|
Other and unspecified disorders of the nervous system
|
350.1–350.2
|
Trigeminal nerve disorders
|
350.8–350.9
|
Trigeminal nerve disorders
|
351.0–351.1
|
Facial nerve disorder
|
351.8–351.9
|
Facial nerve disorder
|
352.0–352.6
|
Disorders of other cranial nerves
|
352.9
|
Disorders of other cranial nerves
|
357.5
|
Alcoholic polyneuropathy
|
360.00–360.04
|
Purulent endophthalmitis
|
360.11–360.14
|
Other endophthalmitis
|
360.19
|
Other endophthalmitis
|
368.11
|
Sudden vision loss
|
368.2
|
Diplopia
|
368.30–368.31
|
Other disorders of binocular vision
|
368.34
|
Abnormal retinal correspondence
|
368.40–368.47
|
Visual field defect
|
368.8–368.9
|
Other/unspecified visual disturbances
|
369.60
|
Profound vision impairment, one eye, level not further specified
|
376.00–376.04
|
Acute inflammation of orbit
|
376.10–376.13
|
Chronic inflammation of orbit
|
376.21–376.22
|
Endocrine exophthalmos
|
376.30–376.36
|
Other exophthalmic conditions
|
376.47
|
Deformity of orbit due to trauma or surgery
|
377.00–377.01
|
Papilledema
|
377.30–377.34
|
Optic neuritis
|
377.39
|
Other optic neuritis
|
377.41–377.43
|
Ischemic optic neuropathy – Optic nerve hypoplasia
|
377.49
|
Other disorders of optic nerve
|
377.51–377.54
|
Disorders of optic chiasm
|
377.71–377.73
|
Disorders of visual cortex
|
377.75
|
Cortical blindness
|
378.50–378.56
|
Paralytic strabismus
|
378.60–378.63
|
Mechanical strabismus
|
378.71–378.73
|
Other specified strabismus
|
378.81–378.86
|
Other disorders of binocular eye movements
|
379.50–379.59
|
Nystagmus and other irregular eye movements
|
379.91–379.92
|
Unspecified disorder of eye and adnexa
|
380.14–380.16
|
Infective otitis externa
|
380.50–380.53
|
Acquired stenosis of external ear canal
|
381.10
|
Chronic serous otitis media, simple or unspecified
|
381.19
|
Other chronic serous otitis media
|
381.20
|
Chronic mucoid otitis media, simple or unspecified
|
381.29
|
Other chronic mucoid otitis media
|
381.3–381.4
|
Non-suppurative otitis media and Eustachian tube disorder
|
385.00–385.03
|
Tympanosclerosis
|
385.09
|
Tympanosclerosis involving other combination of structures
|
385.10–385.13
|
Adhesive middle ear disease
|
385.21–385.24
|
Other acquired abnormality of ear ossicles
|
385.30–385.33
|
Cholesteatoma of middle ear and mastoid
|
385.89
|
Other disorders of middle ear and mastoid
|
386.00–386.04
|
Ménière’s disease, unspecified
|
386.10–386.12
|
Other and unspecified peripheral vertigo
|
386.19
|
Other peripheral vertigo
|
386.2
|
Vertigo of central origin
|
386.30–386.35
|
Labyrinthitis
|
386.40–386.43
|
Labyrinthine fistula
|
386.48
|
Labyrinthine fistula of combined sites
|
386.50–386.56
|
Labyrinthine dysfunction
|
386.58
|
Other forms and combinations of labyrinthine dysfunction
|
386.8–386.9
|
Vertiginous syndromes and other disorders of vestibular system
|
387.0–387.2
|
Otosclerosis
|
387.8–387.9
|
Otosclerosis
|
388.5
|
Disorders of acoustic nerve
|
388.61
|
Cerebrospinal fluid otorrhea
|
389.10–389.18
|
Sensorineural hearing loss
|
389.20–389.22
|
Mixed hearing loss
|
389.8
|
Other specified forms of hearing loss
|
401.9
|
Unspecified essential hypertension
|
427.31–427.32
|
Atrial fibrillation and flutter
|
430
|
Subarachnoid hemorrhage
|
431
|
Intracerebral hemorrhage
|
432.0–432.1
|
Other and unspecified intracranial hemorrhage
|
432.9
|
Unspecified intracranial hemorrhage
|
433.00–433.01
|
Occlusion and stenosis of basilar artery
|
433.10–433.11
|
Occlusion and stenosis of carotid artery
|
433.20–433.21
|
Occlusion and stenosis of vertebral artery
|
433.30–433.31
|
Occlusion and stenosis of multiple and bilateral arteries
|
433.80–433.81
|
Occlusion and stenosis of specified precerebral artery
|
433.90–433.91
|
Occlusion and stenosis of unspecified precerebral artery
|
434.00–434.01
|
Cerebral thrombosis
|
434.10–434.11
|
Cerebral embolism
|
434.90–434.91
|
Cerebral artery occlusion
|
435.0–435.3
|
Transient cerebral ischemia
|
435.8–435.9
|
Transient cerebral ischemia
|
436
|
Acute but ill-defined cerebrovascular disease
|
437.0–437.9
|
Other and ill-defined cerebrovascular disease
|
438.0
|
Late effects of cerebrovascular disease, cognitive deficits
|
438.10–438.13
|
Late effects of cerebrovascular disease, speech and language deficits
|
438.19
|
Late effects of cerebrovascular disease, other speech and language deficits
|
438.20–438.22
|
Late effects of cerebrovascular disease, hemiplegia/hemiparesis
|
438.30–438.32
|
Late effects of cerebrovascular disease, monoplegia of upper limb
|
438.40–438.42
|
Late effects of cerebrovascular disease, monoplegia of lower limb
|
438.50–438.53
|
Late effects of cerebrovascular disease, other paralytic syndrome
|
438.6–438.7
|
Other late effects of cerebrovascular disease
|
438.81–438.85
|
Other late effects of cerebrovascular disease
|
438.89
|
Other late effects of cerebrovascular disease
|
438.9
|
Unspecified late effects of cerebrovascular disease
|
446.0
|
Polyarteritis nodosa
|
446.5–446.7
|
Polyarteritis nodosa and allied conditions
|
447.8
|
Other specified disorders of arteries and arterioles
|
448.0
|
Hereditary hemorrhagic telangiectasia
|
461.0–461.3
|
Acute sinusitis
|
461.8–461.9
|
Acute sinusitis
|
473.0
|
Chronic maxillary sinusitis
|
473.3
|
Chronic sphenoidal sinusitis
|
478.19
|
Other disease of nasal cavity and sinuses
|
478.20–478.22
|
Other diseases of pharynx, not elsewhere classified
|
478.24–478.26
|
Other diseases of pharynx, not elsewhere classified
|
478.29
|
Other diseases of pharynx, not elsewhere classified
|
522.8
|
Radicular cyst
|
524.00–524.06
|
Major anomalies of jaw size
|
524.09
|
Other specified jaw size anomalies
|
524.10–524.12
|
Anomalies of relationship of jaw to cranial base
|
524.19
|
Anomalies of relationship of jaw to cranial base, other specified anomaly
|
524.60–524.63
|
Temporomandibular joint disorders
|
524.69
|
Other specified temporomandibular joint disorders
|
526.0–526.4
|
Diseases of the jaws
|
526.81
|
Diseases of the jaws, exostosis of jaw
|
526.89
|
Diseases of the jaws, other
|
526.9
|
Diseases of the jaws, unspecified
|
668.20–668.24
|
Central nervous system complications of the administration of anesthetic or other sedation in labor and delivery
|
671.50–671.54
|
Venous complications in pregnancy and the puerperium, other phlebitis and thrombosis
|
674.00–674.04
|
Cerebrovascular disorders in the puerperium
|
709.00–709.01
|
Other disorders of skin and subcutaneous tissue, dyschromia
|
709.09
|
Other disorders of skin and subcutaneous tissue, dyschromia, other
|
731.0
|
Osteitis deformans without mention of bone tumor, Paget’s disease
|
731.3
|
Major osseous defects
|
740.0–740.1
|
Anencephalus and similar anomalies
|
741.00–741.03
|
Spina bifida with hydrocephalus
|
741.90–741.93
|
Spina bifida without mention of hydrocephalus
|
742.0–742.4
|
Other congenital anomalies of the nervous system
|
742.8–742.9
|
Other congenital anomalies of the nervous system
|
744.41–744.42
|
Brachial cleft cyst or fistula; preauricular sinus
|
747.81
|
Anomalies of cerebrovascular system
|
748.0–748.1
|
Congenital anomalies of respiratory system
|
749.00–749.04
|
Cleft palate
|
749.10–749.14
|
Cleft lip
|
749.20–749.25
|
Cleft palate with cleft lip
|
754.0
|
Certain congenital musculoskeletal deformities of skull, face and jaw
|
756.0
|
Congenital anomalies of skull and face bones
|
756.9
|
Other and unspecified anomalies of musculoskeletal system
|
757.0–757.2
|
Congenital anomalies of the integument
|
757.31–757.32
|
Other specified anomalies of skin
|
759.5–759.6
|
Other and unspecified congenital anomalies
|
759.81–759.83
|
Other specified anomalies
|
759.89
|
Other specified anomalies
|
762.1
|
Other forms of placental separation and hemorrhage
|
767.0
|
Subdural and cerebral hemorrhage
|
767.8
|
Other specified birth trauma
|
768.70–768.73
|
Hypoxic ischemic encephalopathy (HIE)
|
771.1–771.2
|
Infections specific to the perinatal period
|
772.10–772.14
|
Intraventricular hemorrhage of fetus or newborn
|
772.2
|
Subarachnoid hemorrhage
|
774.7
|
Kernicterus not due to isoimmunization (bilirubin encephalopathy)
|
776.4
|
Polycythemia neonatorum
|
780.01–780.02
|
Alteration of consciousness
|
780.09
|
Alteration of consciousness, other
|
780.2
|
Syncope and collapse
|
780.31–780.33
|
Febrile convulsions (simple), unspecified – Complex febrile convulsions
|
780.39
|
Other convulsions
|
780.4
|
Dizziness and giddiness
|
780.60
|
Fever, unspecified
|
780.65
|
Hypothermia not associated with low environmental temperature
|
780.71
|
Chronic fatigue syndrome
|
780.79
|
Other malaise and fatigue
|
781.0–781.4
|
Symptoms involving nervous and musculoskeletal systems
|
781.6
|
Meningismus
|
781.8
|
Neurologic neglect syndrome
|
782.0
|
Disturbance of skin sensation
|
784.0
|
Headache
|
784.2–784.3
|
Symptoms involving head and neck
|
784.49
|
Other voice and resonance disorders
|
784.51
|
Dysarthria
|
784.60–784.61
|
Other symbolic dysfunction
|
784.69
|
Other symbolic dysfunction
|
784.92
|
Jaw pain
|
785.50–785.51
|
Shock without mention of trauma
|
793.0
|
Nonspecific (abnormal) findings on radiological and other examination of skull and head
|
793.91
|
Image test inconclusive due to excess body fat
|
793.99
|
Other nonspecific abnormal findings on radiological and other examinations of body structure
|
794.00–794.02
|
Non-specific abnormal results of function studies, brain and central nervous system
|
794.10–794.17
|
Non-specific abnormal results of function studies, peripheral nervous system and special senses
|
794.19
|
Abnormal function studies, nervous system and special senses, other
|
797
|
Senility without mention of psychosis
|
800.00–800.06
|
Fracture of vault of skull, closed without mention of intracranial injury
|
800.09
|
Fracture of vault of skull, closed without mention of intracranial injury, with concussion, unspecified
|
800.10–800.16
|
Fracture of vault of skull, closed with cerebral laceration and contusion
|
800.19
|
Fracture of vault of skull, closed with cerebral laceration and contusion, with concussion, unspecified
|
800.20–800.26
|
Fracture of vault of skull, closed with subarachnoid, subdural, and extradural hemorrhage
|
800.29
|
Fracture of vault of skull, closed with subarachnoid, subdural, and extradural hemorrhage, with concussion, unspecified
|
800.30–800.36
|
Fracture of vault of skull, closed with other and unspecified intracranial hemorrhage
|
800.39
|
Fracture of vault of skull, closed with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
800.40–800.46
|
Fracture of vault of skull, closed with intracranial injury of other and unspecified nature
|
800.49
|
Fracture of vault of skull, closed with intracranial injury of other and unspecified nature, with concussion, unspecified
|
800.50–800.56
|
Fracture of vault of skull, open without mention of intracranial injury
|
800.59
|
Fracture of vault of skull, open without mention of intracranial injury, with concussion, unspecified
|
800.60–800.66
|
Fracture of vault of skull, open with cerebral laceration and contusion
|
800.69
|
Fracture of vault of skull, open with cerebral laceration and contusion, with concussion, unspecified
|
800.70–800.76
|
Fracture of vault of skull, open with subarachnoid, subdural, and extradural hemorrhage
|
800.79
|
Fracture of vault of skull, open with subarachnoid, subdural, and extradural hemorrhage, with concussion, unspecified
|
800.80–800.86
|
Fracture of vault of skull, open with other and unspecified intracranial hemorrhage
|
800.89
|
Fracture of vault of skull, open with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
800.90–800.96
|
Fracture of vault of skull, open with intracranial injury of other and unspecified nature
|
800.99
|
Fracture of vault of skull, open with intracranial injury of other and unspecified nature, with concussion, unspecified
|
801.00–801.06
|
Fracture of base of skull, closed without mention of intracranial injury
|
801.09
|
Fracture of base of skull, closed without mention of intracranial injury, with concussion, unspecified
|
801.10–801.16
|
Fracture of base of skull, closed with cerebral laceration and contusion
|
801.19
|
Fracture of base of skull, closed with cerebral laceration and contusion, with concussion, unspecified
|
801.20–801.26
|
Fracture of base of skull, closed with subarachnoid, subdural and extradural hemorrhage
|
801.29
|
Fracture of base of skull, closed with subarachnoid, subdural and extradural hemorrhage, with concussion, unspecified
|
801.30–801.36
|
Fracture of base of skull, closed with other and unspecified intracranial hemorrhage
|
801.39
|
Fracture of base of skull, closed with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
801.40–801.46
|
Fracture of base of skull, closed with intracranial injury of other and unspecified nature
|
801.49
|
Fracture of base of skull, closed with intracranial injury of other and unspecified nature, with concussion, unspecified
|
801.50–801.56
|
Fracture of base of skull, open without mention of intracranial injury
|
801.59
|
Fracture of base of skull, open without mention of intracranial injury, with concussion, unspecified
|
801.60–801.66
|
Fracture of base of skull, open with cerebral laceration and contusion
|
801.69
|
Fracture of base of skull, open with cerebral laceration and contusion, with concussion, unspecified
|
801.70–801.76
|
Fracture of base of skull, open with subarachnoid, subdural, and extradural hemorrhage
|
801.79
|
Fracture of base of skull, open with subarachnoid, subdural, and extradural hemorrhage, with concussion, unspecified
|
801.80–801.86
|
Fracture of base of skull, open with other and unspecified intracranial hemorrhage
|
801.89
|
Fracture of base of skull, open with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
801.90–801.96
|
Fracture of base of skull, open with intracranial injury of other and unspecified nature
|
801.99
|
Fracture of base of skull, open with intracranial injury of other and unspecified nature, with concussion, unspecified
|
802.0–802.1
|
Fracture, nasal bones
|
802.20–802.29
|
Fracture, mandible, closed
|
802.30–802.39
|
Fracture, mandible, open
|
802.4–802.9
|
Fracture of face bones
|
803.00–803.06
|
Other and unqualified skull fractures, closed without mention of intracranial injury
|
803.09
|
Other and unqualified skull fractures, closed without mention of intracranial injury, with concussion, unspecified
|
803.10–803.16
|
Other and unqualified skull fractures, closed with cerebral laceration and contusion
|
803.19
|
Other and unqualified skull fractures, closed with cerebral laceration and contusion, with concussion, unspecified
|
803.20–803.26
|
Other and unqualified skull fractures, closed with subarachnoid, subdural and extradural hemorrhage
|
803.29
|
Other and unqualified skull fractures, closed with subarachnoid, subdural and extradural hemorrhage, with concussion, unspecified
|
803.30–803.36
|
Other and unqualified skull fractures, closed with other and unspecified intracranial hemorrhage
|
803.39
|
Other and unqualified skull fractures, closed with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
803.40–803.46
|
Other and unqualified skull fractures, closed with intracranial injury of other and unspecified nature
|
803.49
|
Other and unqualified skull fractures, closed with intracranial injury of other and unspecified nature, with concussion, unspecified
|
803.50–803.56
|
Other and unqualified skull fractures, open without mention of intracranial injury
|
803.59
|
Other and unqualified skull fractures, open without mention of intracranial injury, with concussion, unspecified
|
803.60–803.66
|
Other and unqualified skull fractures, open with cerebral laceration and contusion
|
803.69
|
Other and unqualified skull fractures, open with cerebral laceration and contusion, with concussion, unspecified
|
803.70–803.76
|
Other and unqualified skull fractures, open with subarachnoid, subdural and extradural hemorrhage
|
803.79
|
Other and unqualified skull fractures, open with subarachnoid, subdural and extradural hemorrhage, with concussion, unspecified
|
803.80–803.86
|
Other and unqualified skull fractures, open with other and unspecified intracranial hemorrhage
|
803.89
|
Other and unqualified skull fractures, open with other and unspecified intracranial hemorrhage with concussion, unspecified
|
803.90–803.96
|
Other and unqualified skull fractures, open with intracranial injury of other and unspecified nature
|
803.99
|
Other and unqualified skull fractures, open with intracranial injury of other and unspecified nature, with concussion, unspecified
|
804.00–804.06
|
Multiple fractures involving skull or face with other bones, closed without mention of intracranial injury
|
804.09
|
Multiple fractures involving skull or face with other bones, closed without mention of intracranial injury, with concussion, unspecified
|
804.10–804.16
|
Multiple fractures involving skull or face with other bones, closed with cerebral laceration and contusion
|
804.19
|
Multiple fractures involving skull or face with other bones, closed with cerebral laceration and contusion, with concussion, unspecified
|
804.20–804.26
|
Multiple fractures involving skull or face with other bones, closed with subarachnoid, subdural and extradural hemorrhage
|
804.29
|
Multiple fractures involving skull or face with other bones, closed with subarachnoid, subdural and extradural hemorrhage, with concussion, unspecified
|
804.30–804.36
|
Multiple fractures involving skull or face with other bones, closed with other and unspecified intracranial hemorrhage
|
804.39
|
Multiple fractures involving skull or face with other bones, closed with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
804.40–804.46
|
Multiple fractures involving skull or face with other bones, closed with intracranial injury of other and unspecified nature
|
804.49
|
Multiple fractures involving skull or face with other bones, closed with intracranial injury of other and unspecified nature, with concussion, unspecified
|
804.50–804.56
|
Multiple fractures involving skull or face with other bones, open without mention of intracranial injury
|
804.59
|
Multiple fractures involving skull or face with other bones, open without mention of intracranial injury, with concussion, unspecified
|
804.60–804.66
|
Multiple fractures involving skull or face with other bones, open with cerebral laceration and contusion
|
804.69
|
Multiple fractures involving skull or face with other bones, open with cerebral laceration and contusion, with concussion, unspecified
|
804.70–804.76
|
Multiple fractures involving skull or face with other bones, open with subarachnoid, subdural and extradural hemorrhage
|
804.79
|
Multiple fractures involving skull or face with other bones, open with subarachnoid, subdural and extradural hemorrhage, with concussion, unspecified
|
804.80–804.86
|
Multiple fractures involving skull or face with other bones, open with other and unspecified intracranial hemorrhage
|
804.89
|
Multiple fractures involving skull or face with other bones, open with other and unspecified intracranial hemorrhage, with concussion, unspecified
|
804.90–804.96
|
Multiple fractures involving skull or face with other bones, open with intracranial injury of other and unspecified nature
|
804.99
|
Multiple fractures involving skull or face with other bones, open with intracranial injury of other and unspecified nature, with concussion, unspecified
|
830.0–830.1
|
Dislocation of jaw
|
850.0
|
Concussion, with no loss of consciousness
|
850.11–850.12
|
Concussion, with brief loss of consciousness
|
850.2–850.5
|
Concussion
|
850.9
|
Concussion, unspecified
|
851.00–851.06
|
Cerebral laceration and contusion, cortex (cerebral) contusion without mention of open intracranial wound
|
851.09
|
Cerebral laceration and contusion, cortex (cerebral) contusion without mention of open intracranial wound, with concussion, unspecified
|
851.10–851.16
|
Cerebral laceration and contusion, cortex (cerebral) contusion with open intracranial wound
|
851.19
|
Cerebral laceration and contusion, cortex (cerebral) contusion with open intracranial wound, with concussion, unspecified
|
851.20–851.26
|
Cerebral laceration and contusion, cortex (cerebral) laceration without mention of open intracranial wound
|
851.29
|
Cerebral laceration and contusion, cortex (cerebral) laceration without mention of open intracranial wound, with concussion, unspecified
|
851.30–851.36
|
Cerebral laceration and contusion, cortex (cerebral) laceration with open intracranial wound
|
851.39
|
Cerebral laceration and contusion, cortex (cerebral) laceration with open intracranial wound, with concussion, unspecified
|
851.40–851.46
|
Cerebral laceration and contusion, cerebellar or brain stem contusion without mention of open intracranial wound
|
851.49
|
Cerebral laceration and contusion, cerebellar or brain stem contusion without mention of open intracranial wound, with concussion, unspecified
|
851.50–851.56
|
Cerebral laceration and contusion, cerebellar or brain stem contusion with open intracranial wound
|
851.59
|
Cerebral laceration and contusion, cerebellar or brain stem contusion with open intracranial wound, with concussion, unspecified
|
851.60–851.66
|
Cerebral laceration and contusion, cerebellar or brain stem laceration without mention of open intracranial wound
|
851.69
|
Cerebral laceration and contusion, cerebellar or brain stem contusion without mention of open intracranial wound, with concussion, unspecified
|
851.70–851.76
|
Cerebral laceration and contusion, cerebellar or brain stem laceration with open intracranial wound
|
851.79
|
Cerebral laceration and contusion, cerebellar or brain stem laceration with open intracranial wound, with concussion, unspecified
|
851.80–851.86
|
Cerebral laceration and contusion, other and unspecified cerebral laceration and contusion, without mention of open intracranial wound
|
851.89
|
Cerebral laceration and contusion, other and unspecified cerebral laceration and contusion, without mention of open intracranial wound, with concussion, unspecified
|
851.90–851.96
|
Cerebral laceration and contusion, other and unspecified cerebral laceration and contusion, with open intracranial wound
|
851.99
|
Cerebral laceration and contusion, other and unspecified cerebral laceration and contusion, with open intracranial wound, with concussion, unspecified
|
852.00–852.06
|
Subarachnoid, subdural and extradural hemorrhage following injury, subarachnoid hemorrhage following injury without mention of open intracranial wound
|
852.09
|
Subarachnoid, subdural and extradural hemorrhage following injury, subarachnoid hemorrhage following injury without mention of open intracranial wound, with concussion, unspecified
|
852.10–852.16
|
Subarachnoid, subdural and extradural hemorrhage following injury, subarachnoid hemorrhage following injury with open intracranial wound
|
852.19
|
Subarachnoid, subdural and extradural hemorrhage following injury, subarachnoid hemorrhage following injury with open intracranial wound, with concussion, unspecified
|
852.20–852.26
|
Subarachnoid, subdural and extradural hemorrhage following injury, subdural hemorrhage following injury without mention of open intracranial wound
|
852.29
|
Subarachnoid, subdural and extradural hemorrhage following injury, subdural hemorrhage following injury without mention of open intracranial wound, with concussion, unspecified
|
852.30–852.36
|
Subarachnoid, subdural and extradural hemorrhage following injury, subdural hemorrhage following injury with open intracranial wound
|
852.39
|
Subarachnoid, subdural and extradural hemorrhage following injury, subdural hemorrhage following injury with open intracranial wound, with concussion, unspecified
|
852.40–852.46
|
Subarachnoid, subdural and extradural hemorrhage following injury, extradural hemorrhage following injury without mention of open intracranial wound
|
852.49
|
Subarachnoid, subdural and extradural hemorrhage following injury, extradural hemorrhage following injury without mention of open intracranial wound, with concussion, unspecified
|
852.50–852.56
|
Subarachnoid, subdural and extradural hemorrhage following injury, extradural hemorrhage following injury with open intracranial wound
|
852.59
|
Subarachnoid, subdural and extradural hemorrhage following injury, extradural hemorrhage following injury with open intracranial wound, with concussion, unspecified
|
853.00–853.06
|
Other and unspecified intracranial hemorrhage following injury, without mention of open intracranial wound
|
853.09
|
Other and unspecified intracranial hemorrhage following injury, without mention of open intracranial wound, with concussion, unspecified
|
853.10–853.16
|
Other and unspecified intracranial hemorrhage following injury, with open intracranial wound
|
853.19
|
Other and unspecified intracranial hemorrhage following injury, with open intracranial wound, with concussion, unspecified
|
854.00–854.06
|
Intracranial injury of other and unspecified nature, without mention of open intracranial wound, unspecified state of consciousness
|
854.09
|
Intracranial injury of other and unspecified nature, without mention of open intracranial wound, with concussion, unspecified
|
854.10–854.16
|
Intracranial injury of other and unspecified nature, with open intracranial wound
|
854.19
|
Intracranial injury of other and unspecified nature, with open intracranial wound, with concussion, unspecified
|
870.0–870.4
|
Open wound of ocular adnexa
|
870.8–870.9
|
Open wound of ocular adnexa
|
871.0–871.7
|
Open wound of eyeball
|
871.9
|
Open wound of eyeball, unspecified
|
872.00–872.02
|
Open wound of ear, external ear
|
872.10–872.12
|
Open wound of ear, external ear, complicated
|
872.61–872.64
|
Open wound of ear, other specified parts of ear without mention of complication
|
872.69
|
Open wound of ear, other specified parts of ear without mention of complication, other and multiple sites
|
872.71–872.74
|
Open wound of ear, other specified parts of ear, complicated
|
872.79
|
Open wound of ear, other specified parts of ear, complicated, other and multiple sites
|
873.0–873.1
|
Other open wound of head, scalp
|
873.20–873.23
|
Other open wound of head, nose, without mention of complication
|
873.29
|
Other open wound of head, nose, multiple sites, without mention of complication
|
873.30–873.33
|
Other open wound of head, nose, complicated
|
873.39
|
Other open wound of head, nose, complicated, multiple sites
|
873.40–873.44
|
Other open wound of head, face, without mention of complication
|
873.49
|
Other open wound of head, face, without mention of complication, other and multiple sites
|
873.50–873.54
|
Other open wound of head, face, complicated
|
873.59
|
Other open wound of head, face, complicated, other and multiple sites
|
873.60–873.65
|
Open wound of mouth unspecified site uncomplicated – Open wound of palate uncomplicated
|
873.69
|
Other open wound of head, internal structures of mouth without mention of complication, other and multiple sites
|
873.70–873.75
|
Open wound of mouth unspecified site complicated – Open wound of palate complicated
|
873.79
|
Other open wound of head, internal structures of mouth, complicated, other and multiple sites
|
873.8–873.9
|
Other open wound of head
|
874.00–874.02
|
Open wound of larynx and trachea, without mention of complication
|
874.10–874.12
|
Open wound of larynx and trachea, complicated
|
874.2–874.5
|
Open wound of neck
|
874.8–874.9
|
Open wound of neck
|
900.00–900.03
|
Injury to carotid artery
|
900.1
|
Injury to internal jugular vein
|
900.81–900.82
|
Injury to other specified blood vessels of head and neck
|
900.89
|
Injury to other blood vessels of head and neck
|
905.0
|
Late effect of fracture of skull and face bones
|
906.0
|
Late effect of open wound of head and neck, trunk
|
906.5
|
Late effect of burn of eye, face, head, neck
|
907.0
|
Late effect of intracranial injury without mention of skull fracture
|
908.3
|
Late effect of injury to blood vessel of head, neck, extremities
|
908.6
|
Late effect of certain complications of trauma
|
920
|
Contusion of face, scalp, and neck except eye(s)
|
921.2–921.3
|
Contusion of eyeball and adnexa
|
921.9
|
Unspecified contusion of eye
|
925.1–925.2
|
Crushing injury of face, scalp and neck
|
950.0–950.3
|
Injury to optic nerve and pathways
|
950.9
|
Injury to optic nerve and pathways, unspecified
|
951.0–951.9
|
Injury to other cranial nerves
|
959.01
|
Head injury, unspecified
|
967.0
|
Poisoning by barbiturates
|
969.00–969.05
|
Poisoning by antidepressants
|
969.09
|
Poisoning by other antidepressants
|
969.1–969.6
|
Poisoning by psychotropic agents
|
969.70–969.73
|
Poisoning by psychostimulants
|
969.79
|
Poisoning by other psychostimulants
|
969.8–969.9
|
Poisoning by psychotropic agents
|
996.2
|
Mechanical complication of nervous system device, implant and graft
|
996.51–996.53
|
Mechanical complication of other prosthetic device, implant and graft
|
996.59
|
Mechanical complication due to other implant and internal device, not elsewhere classified
|
996.63
|
Infection and inflammatory reaction due to nervous system device, implant and graft
|
996.75
|
Other complications due to a nervous system device, implant and graft
|
997.00–997.02
|
Nervous system complications
|
997.09
|
Nervous system complications, other
|
998.11–998.13
|
Hemorrhage or hematoma or seroma complicating a procedure
|
998.51
|
Infected postoperative seroma
|
998.59
|
Other postoperative infection
|
V10.22
|
Personal history of malignant neoplasm of nasal cavities, middle ear and accessory sinuses
|
V10.81–V10.84
|
Personal history of malignant neoplasm of other sites
|